JAZZ - Jazz Pharmaceuticals exploring strategic options including sale - Bloomberg
2023-10-19 22:50:09 ET
More on Jazz Pharmaceuticals
- Jazz Pharma: Playing The High Notes With Xywav
- Jazz Pharmaceuticals plc (JAZZ) Q2 2023 Earnings Call Transcript
- Jazz Pharmaceuticals: Depressed Valuation Opens Up Potential
- Ionis, AbbVie, Alnylam draw bullish views at Raymond James
- Jazz Pharma wins EU approval for blood cancer therapy
For further details see:
Jazz Pharmaceuticals exploring strategic options, including sale - Bloomberg